Published 6 days ago • loading... • Updated 5 days ago

FastWave Medical Receives IRB Approval for Sola™, its Novel Coronary Laser IVL (L-IVL) System

Summary by Star Local

Feasibility study for coronary artery disease will commence ahead of FastWave's expected U.S. pivotal trial.

Read with caution - this story is only being covered by one news source that has a ‘low factuality’ rating, which means the outlet has a history of poor reporting practices. Learn more about factuality ratings here.

4 Articles

All

Left

Center

Right

Medical Device Network

FastWave secures approval to begin coronary feasibility study using Sola IVL system

The IRB has granted approval for FastWave to initiate a coronary feasibility study leveraging its Sola L-IVL system.The post FastWave secures approval to begin coronary feasibility study using Sola IVL system appeared first on Medical Device Network.

5 days ago

Read Full Article

COMPACT

Acute coronary syndrome: Before the heart attack comes

Cardiovascular diseases are cause of death No. 1! The acute coronary syndrome includes heart diseases related to... The post Acute coronary syndrome: Before the heart attack comes first appeared on COMPACT.

6 days ago

Read Full Article

Cardiovascular News

FastWave Medical to commence coronary feasibility study of laser IVL system - Cardiovascular News

FastWave Medical FastWave Medical has secured institutional review board (IRB) approval to commence a coronary feasibility study utilising Sola, its novel laser intravascular lithotripsy (L-IVL) system. FastWave is partnering with Clinical Accelerator to achieve this milestone, paving the way for its planned US pivotal trial. FastWave’s next-generation Sola L-IVL system empowers physicians treating cardiovascular calcium with sleek, rupture-resi…

6 days ago

Read Full Article